Graybill, John R.

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 2,660

Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes

Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 791

In Vitro Activity of Caspofungin against Candida albicans Biofilms

Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityBacterial biofilms and quorum sensing

Cited by 288

Caspofungin Resistance in Candida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis

Hernandez, S., López-Ribot, J. L., Najvar, L. K., McCarthy, D. I., Bocanegra, R., & Graybill, J. R. (2004) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 162

Posaconazole for the Treatment of Azole-Refractory Oropharyngeal and Esophageal Candidiasis in Subjects with HIV Infection

Skiest, D. J., Vazquez, J. A., Anstead, G. M., Graybill, J. R., Reynes, J., Ward, D., Hare, R., Boparai, N., & Isaacs, R. (2007) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityHIV/AIDS oral health manifestations

Cited by 162

Pharmacology and toxicity of high-dose ketoconazole

Sugar, A. M., Alsip, S. G., Galgiani, J. N., Graybill, J. R., Dismukes, W. E., Cloud, G. A., Craven, P. C., & Stevens, D. A. (1987) · Antimicrobial Agents and Chemotherapy

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 129

Antifungal Activity of Amphotericin B Cochleates against Candida albicans Infection in a Mouse Model

Zarif, L., Graybill, J. R., Perlin, D., Najvar, L., Bocanegra, R., & Mannino, R. J. (2000) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityNanoparticle-Based Drug Delivery

Cited by 122

Key issues concerning fungistatic versus fungicidal drugs

Graybill, J. R., Burgess, D. S., & Hardin, T. C. (1997) · European Journal of Clinical Microbiology & Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 59

Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis

Alvarez, C. A., Wiederhold, N. P., McConville, J. T., Peters, J. I., Najvar, L. K., Graybill, J. R., Coalson, J. J., Talbert, R. L., Burgess, D. S., Bocanegra, R., et al. (2007) · Journal of Infection

Antifungal resistance and susceptibilityInhalation and Respiratory Drug Delivery

Cited by 43

Granulocyte colony stimulating factor therapy of experimental cryptococcal meningitis

Graybill, J. R., Bocanegra, R., Lambros, C., & Luther, M. F. (1997) · Medical Mycology

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 38